Recently Published Issue of the Journal Current Alzheimer Research

Current Alzheimer Research publishes peer-reviewed frontier review, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer’s disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer’s disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer’s disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer’s disease. Current Alzheimer Research provides a comprehensive ‘bird’s-eye view’ of the current state of Alzheimer’s research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.

Following are the articles from the Journal of Current Alzheimer Research, 12 Issue 5:

Article: Editorial (Thematic Issue: Small Molecule Therapeutics for Alzheimer’s Disease)

Author(s): Dik-Lung Ma and Chung-Hang Leung


Article: Syntheses and Evaluation of Asymmetric Curcumin Analogues as Potential Multifunctional Agents for the Treatment of Alzheimer’s Disease

Author(s): Peng Zhai, Chun-Li Xia, Jia-Heng Tan, Ding Li, Tian-Miao Ou, Shi-Liang Huang, Lian-Quan Gu and Zhi-Shu Huang


Article: Inhibitory Activity of Curcumin Derivatives Towards Metal-Free and Metal-Induced Amyloid-β Aggregation

Author(s): Akiko Kochi, Hyuck Jin Lee, Sashiprabha M. Vithanarachchi, Vediappen Padmini, Matthew J. Allen and Mi Hee Lim


Article: Inhibition of β-Amyloid Aggregation by Albiflorin, Aloeemodin and Neohesperidin and their Neuroprotective Effect on Primary Hippocampal Cells Against β-Amyloid Induced Toxicity

Author(s): See-Lok Ho, Chung-Yan Poon, Chengyuan Lin, Ting Yan, Daniel Wai-Jing Kwong, Ken Kin-Lam Yung, Man S. Wong, Zhaoxiang Bian and Hung-Wing Li

Article: A Novel Tetradentate Ruthenium(II) Complex Containing Tris(2- pyridylmethyl)amine (tpa) as an Inhibitor of Beta-Amyloid Fibrillation

Author(s): Sharon Lai-Fung Chan, Lihua Lu, Tsz Lung Lam, Siu-Cheong Yan, Chung-Hang Leung and Dik-Lung Ma


Article: Dual Inhibition and Monitoring of Beta-Amyloid Fibrillation by a Luminescent Iridium(III) Complex

Author(s): Chun-Yuen Wong, Lai-Hon Chung, Lihua Lu, Modi Wang, Bingyong He, Li-Juan Liu, Chung-Hang Leung and Dik-Lung Ma

Article: Small Molecules and Alzheimer’s Disease: Misfolding, Metabolism and Imaging

Author(s): Viharkumar Patel, Xueli Zhang, Nicolas A. Tautiva, Akwe N. Nyabera, Opeyemi O. Owa, Melvin Baidya, Hee Chang Sung, Pardeep S. Taunk, Shahrzad Abdollahi, Stacey Charles, Rachel A. Gonnella, Nikhita Gadi, Karen T. Duong, Janelle N. Fawver, Chongzhao Ran, Tuula O. Jalonen and Ian V.J. Murray


Article: Alzheimer’s Disease, Astrocytes and Kynurenines

Author(s): Livia Dezsi, Bernadett Tuka, Diana Martos and Laszlo Vecsei


Article: 1950 MHz Electromagnetic Fields Ameliorate Aβ Pathology in Alzheimer’s Disease Mice

Author(s): Ye Ji Jeong, Ga-Young Kang, Jong Hwa Kwon, Hyung-Do Choi, Jeong-Ki Pack, Nam Kim, Yun-Sil Lee and Hae-June Lee


Article: Functional Activities Questionnaire Items that Best Discriminate and Predict Progression from Clinically Normal to Mild Cognitive Impairment

Author(s): Gad A. Marshall, Amy S. Zoller, Natacha Lorius, Rebecca E. Amariglio, Joseph J. Locascio, Keith A. Johnson, Reisa A. Sperling, Dorene M. Rentz and for the Alzheimer’s Disease Neuroimaging Initiative


For details, please visit:

Publishing Ethics And Rectitude

The publication of science involves conscientious, systematic and comprehensive processes by publishers and editors which require to be dealt with efficiently and competently. To maintain high ethical standards of publication of quality science the publisher strives to work closely at all times with journal editors, authors and peer-reviewers. The ethics statement for Bentham Science Publishers (BSP) journals is based on those by the Committee on Publication Ethics (COPE) Code of Conduct guidelines available at

The essentials of BSP’s publishing ethics for all groups involved in the publishing process are as follows:

Editors’ Responsibilities

  • The editor of a journal holds a vital position taking important editorial decisions on all peer-reviewed submitted for publication.
  • The editor should maintain the transparency of the academic research & record, preclude professional needs from cooperating ethical standards, and always be willing to publish retractions, rectifications, and erratum when required.
  • The editor should assess manuscripts for their scientific quality and intellectual content, free from any sort of biased decisions based on discrimination of race, gender, geographical origin, or religion of the author(s). The editor should evaluate manuscripts objectively based on their academic merit free of any commercial or self-interests.
  • The editor should not disclose any information on submitted manuscripts before publication of the manuscript.
  • Promoting research rectitude must be preserved. If at any stage the publisher suspects any kind of misconduct in research, it should be investigated promptly in detail with suitable authority; and if any suspicious act of misconduct is observed in the peer review, it should be resolved with diligence.

Reviewers’ Responsibilities

  • Providing a detailed, constructive, and unbiased evaluation in a timely manner on the scientific content of the work.
  • Indicating whether the writing is relevant, concise & clear and evaluating the originality and scientific accuracy.
  • Maintaining the confidentiality of the complete review process.
  • Notifying the journal editor about any financial or personal conflict of interest and declining to review the manuscript when a possibility of such a conflict exists.
  • Notifying the journal editor of any ethical concerns in their evaluation of submitted manuscripts; such as any violation of ethical treatment of animal or human subjects or any considerable similarity between the previously published article and any reviewed manuscript.

Authors’ Responsibilities

  • The work reported in the manuscript must be all original. All submitted manuscripts must be devoid of any plagiarism and must not have been published earlier or submitted to another journal(s) at the same time.
  • All clinical investigations must be conducted according to the Declaration of Helsinki principles. For research involving animals, the authors should indicate whether the procedures followed were in accordance with the approved standards.
  • Any potential conflict of interest must be clearly acknowledged.
  • Proper acknowledgements to other work reported (individual/company/institution) must be given. Permission must be obtained from any content used from other sources.
  • Authorship should be limited to those who have made a substantial contribution to the interpretation or composition of the submitted work. All authors who have made important contributions should be mentioned as co-authors.

Publishers’ Responsibilities

  • BSP is committed to working with editors to clearly state the relevant roles of the editors and of the publisher in order to ensure the transparency of editorial decisions and as outlined above.
  • BSP ensures the integrity autonomy and originality of each published article with respect to:
    • publication and research fundings
    • publication ethics and rectitude
    • conflicts of interest
    • confidentiality
    • authorship
    • article modifications
    • timely publication of content.


New Issue Published in the Journal Current Aging Science

Current Aging Science publishes frontier review and experimental articles in all areas of aging and age-related research that may influence longevity. This multidisciplinary journal will help in understanding the biology and mechanism of aging, genetics, pathogenesis, intervention of normal aging process and preventive strategies of age-related disorders. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, clinical, molecular, and animal models, including lower organism models (e.g., yeast, Caenorhabditis elegans and Drosophila). In addition to the affect of aging on integrated systems, the journal also covers original articles on recent research in fast emerging areas of adults stem cells, brain imaging, calorie restriction, immunosenescence, molecular diagnostics, pharmacology and clinical aspects of aging. Manuscripts are encouraged that relate to developmental programming of aging and the synergistic mechanism of aging with cardiovascular diseases, obesity and neurodegenerative disorders.

Articles from the Volume 8, Issue 1 of the journal Current Aging Science

Article: Aging is Neither a Failure nor an Achievement of Natural Selection

Author(s): Juan Carlos Aledo and Jose Maria Blanco


Article: Early Life Events can Shape Aging and Longevity

Author(s): Andrzej Bartke


Article: Physiological and Comparative Evidence Fails to Confirm an Adaptive Role for Aging in Evolution

Author(s): Alan A. Cohen


Article: Do We Have Genes that Exist to Hasten Aging? New Data, New Arguments, But the Answer is Still No

Author(s): Aubrey D.N.J. de Grey


Article: Solving the Programmed/Non-Programmed Aging Conundrum

Author(s): Theodore C. Goldsmith


Article: Is the Evolutionary Programmed/ Non-programmed Aging Argument Moot?

Author(s): Theodore C. Goldsmith


Article: Complex Evolutionary Patterns Revealed by Mitochondrial Genomes of the Domestic Horse

Author(s): T. Ning, J. Li, K. Lin, H. Xiao, S. Wylie, S. Hua, H. Li and Y.-P. Zhang


Article: Towards an Evidence-based Model of Aging

Author(s): Harold L. Katcher


Article: Non-programmed Versus Programmed Aging Paradigm

Author(s): Giacinto Libertini


Article: Inheritance of the Complete Mitochondrial Genomes in Three Different Ploidy Fishes

Author(s): C.-P. You, R.-R. Zhao, J. Hu, S.-J. Liu, M. Tao, C. Zhang, Y.-B. Chen, Q.-B. Qin, J. Xiao, W. Duan and Y. Liu


Article: Is Programmed Aging a Cause for Optimism?

Author(s): Josh Mitteldorf


Article: Chronographic Theory of Development, Aging, and Origin of Cancer: Role of Chronomeres and Printomeres

Author(s): Alexey M. Olovnikov


Article: The Interrelationship Between Disease and Ageing and the Implications for Longevity

Author(s): Paul K. Potter


Article: Aging as an Evolvability-Increasing Program Which can be Switched Off by Organism to Mobilize Additional Resources for Survival

Author(s): Maxim V. Skulachev, Fedor F. Severin and Vladimir P. Skulachev


Article: Aging as an Optimization Between Cellular Maintenance Requirements and Evolutionary Constraints

Author(s): Quentin Vanhaelen


For details, please visit:




SMI Event:::::::Advances in Cell Based Assays, 10–11th Nov 2015 in London, UK

200X200DESCRIPTION:  Due to improvements in detection technology and sensitivity in drug screening, recent reports predict the cell based assays market to reach $4.7 billion in 2016. With a fresh new agenda for 2015, Advances in Cell Based Assays arrives at the perfect time to expand scientific horizons in key topics such as drug toxicity testing, live imaging, 3D modelling, phenotype screening, formulation in assay development, plus much more! We have worked closely with a leading panel of experts such as AstraZeneca, GSK, Pfizer and Johnson & Johnson, to create a packed programme that has been tailored for an audience of professionals working in regenerative medicine using 3D cell based assays and high-throughput technologies.. For further details and to register, visit

Advances in Cell Based Assays
10 – 11 NOV 2015
Holiday Inn Kensington Forum, London UK

Press Release: Bentham Science Journals – Impact Factors 2014

News release date: June 23, 2015

Dubai, UAE, June 23, 2015: According to the recently released Journal Citation Reports® 2014, 39 Bentham Science Journals have received Impact Factors. Recent Patents On Anti-Cancer Research has the highest impact factor from all Bentham Science Journals. These positive results reflect the overall high quality of research published by Bentham Science.

Following are the top 10 high impact factor journals published by Bentham Science:

Journal Citation Reports (JCR) are annually published by the Institute of Scientific Information, a division of Thomson Reuters. Its purpose is to offer a systematic means to critically evaluate the world’s leading journals, with quantifiable, statistical information based on citation data.

Bentham Science publishes over 100 print & online scholarly subscription journals; website at

Recently Published Issue of the Journal Letters in Organic Chemistry

Letters in Organic Chemistry publishes original letters, mini-reviews and guest edited issue in all areas of organic chemistry including synthesis, bioorganic, medicinal, natural products, organometallic, supramolecular, molecular recognition and physical organic chemistry. The emphasis is to publish quality papers rapidly by taking full advantage of latest technology for both submission and review of the manuscripts.

Articles from the journal Letters in Organic Chemistry, 12 Issue 6:

Article: UHPLC/Q-TOF-MS Technique: Introduction and Applications

Author(s): Hamid Khan and Javed Ali

Article: One-Pot Syntheses of 1H-Pyrazolo[1,2-B]Phthalazine-5,10-Diones and 2-H-Indazolo[2,1-B]Phthalazine-1,6,11(13-H)-Triones in Water by Auto Catalysis

Author(s): Y. Dathu Reddy, P. Praveen Kumar, B. Rama Devi, Venkata Ramana Reddy and P. K. Dubey

Article: Synthesis, Spectral Characterization and Anticancer Activity of New 2,3,6- Substituted Quinazolin-4(3H)-one Derivatives

Author(s): Peddakonda Ramesh, Doddaga Srinivasulu, Polireddy Kishore, Valasani Koteswara Rao and Muttana Vijaya Bhaskara Reddy


Article: Design and Synthesis of Some Carbamazepine Derivatives Using Several Strategies

Author(s): Figueroa-Valverde Lauro, Díaz-Cedillo Francisco, Rosas-Nexticapa Marcela, Maldonado- Velazquez Guadalupe, García-Cervera Elodia, Pool-Gomez Eduardo, Jarquin-Barberena Horacio, Lopez-Ramos Maria, Rodriguez-Hurtado Fernanda and Chan-Salvador Marissa

Article: A New Index for the Estimation of the Aromatic Character – VII

Author(s): Maurizio D’Auria

Article: Synthesis of Dichlorophenyl-, Cyanophenyl- and Quinolinyl-Substituted

Author(s): Clare E. Gutteridge, Sean M. Curtis, Joshua W. Major, Daniel A. Nin, Apurba K. Bhattacharjee, Daniel A. Nichols and Lucia Gerena

Article: A Convenient Synthesis of Partially Benzylated Derivative of β-DGlcpNAc-( 1→3)-β-D-Galp-(1→4)-β-D-Glcp-1-OBn as a Versatile Building Block for Sialyl Lewis X Antigens

Author(s): Sameh E. Soliman, Rafik W. Bassily, Ramadan I. El-Sokkary and Mina A. Nashed

Article: Alkylation of 5-(3-chlorobenzo[b]thien-2-yl)-1,2,4-triazole-3-thione with Epichlorhydrin and the Role of MW and Solid Support in the Reaction

Author(s): Nadjet Rezki, Mohamed Reda Aouad, Mouslim Messali and El Sayed H. El Ashry


Article: A Concise Stereoselective Total Synthesis of (–) – Cephalosporolide D

Author(s): Yapuri Umanadh, Gudaparthi Omprakash and Narahari Srinivasareddy

Article: Synthesis and Evaluation of Thiazolidinedione-Coumarin Adducts as Antidiabetic, Anti-Inflammatory and Antioxidant Agents

Author(s): Garima Mishra, Narsingh Sachan and Pooja Chawla

For details, please visit:


SMI EVENT:::::: COPD (19th to 20th October 2015)

SMI event

SMI event

DESCRIPTION:  SMi’s 7th annual conference on COPD will bring together respiratory leaders and scientific pioneers to strengthen knowledge in combinational therapies, new drugs and personalized treatment as well as discuss the latest advances in strategies for managing exacerbations; and the practicalities of reliable clinical trials. Understanding COPD pulmonary indications through biomarkers will be a major focus as will hearing from a selection of pharmaceutical organisations currently developing scientific trials for COPD. This will include case studies from Novartis, Mundipharma, Janssen and Bayer. Exclusive updates into formulation developments and the manufacturing of dry powder inhalation products, lymphoid follicles in COPD and ACOS (Asthma, COPD, Overlap Syndrome) will be just some of the conference highlights this year. With recent advances in proteomics and transcriptomics allowing for the development of personalised treatment for the precise comorbidity, this really is an un-missable event for those involved in respiratory diseases. For further details and to register, visit

COPD –19 – 20 OCT 2015

Holiday Inn Regents Park, London UK